Effective application of mass-spectrometry tools can optimize biosimilar analysis, reducing development time and cost.
Mario DiPaola
Advertisement
Mario DiPaola is senior scientific director at Charles River Laboratories, Woburn, MA.
Articles by Mario DiPaola
This article discusses why it is important to apply risk analysis, QbD, and DoE in the development of analytical methods.
Advertisement
Latest Updated Articles
Best Practices in Analytical Method Development and TestingOctober 15th 2018
Methods Accelerate Biosimilar AnalysisSeptember 1st 2019
Advertisement
Advertisement
Trending on BioPharm International
1
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
2
argenx Agrees to Buy Unnatural Products in Up to $1.15 Billion Deal
3
J&J’s Dual-Antigen Bispecific Regimen Achieves 73% PSA Response in Advanced Prostate Cancer
4
The BioPharm Brief: argenx Bets on Peptides, a Two-Bispecific Regimen in Prostate Cancer, and a New Take on T-Cell Engagers
5